Antagonistic activities of cell-free supernatants of lactobacilli against extended-spectrum β-lactamase producing Klebsiella pneumoniae and Pseudomonas aeruginosa

Infection and Drug Resistance

Volumn 13, Issue , 2020, Pages 543-552

  El Mokhtar, Mohamed A ^a   Hassanein, Khaled M ^a   Ahmed, Ahmed S ^a   Gad, Gamal F M ^b   Amin, Mohamed M ^c   Hassanein, Osama F E ^d  

^a Assiut University Faculty of Medicine   (Egypt)

^b Minia University   (Egypt)

^c ASWAN UNIVERSITY   (Egypt)

^d Assiut University   (Egypt)

Author keywords

Antibiofilm; ESBL; K pneumoniae; Lactobacilli; P aeruginosa

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; FLUORESCEIN ISOTHIOCYANATE; GENTAMICIN; IMIPENEM; MEROPENEM;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOFILM ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOFILM; CELL FREE SUPERNATANT; CONTROLLED STUDY; DISK DIFFUSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FLOW CYTOMETRY; KIRBY BAUER DISK DIFFUSION; MTT ASSAY; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; SUPERNATANT; TIME KILL TEST; URINE SAMPLING;

EID: 85079896330     PISSN: None     EISSN: 11786973     Source Type: Journal    
DOI: 10.2147/IDR.S235603     Document Type: Article

References (47)

1. Chung PY. The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation. FEMS Microbiol Lett. 2016;363(20):fnw219. doi:10.1093/femsle/fnw219
2. Ahmed SH, Daef EA, Badary MS, Mahmoud MA, Abd-Elsayed AA. Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms. BMC Res Notes. 2009;2:76. doi:10.1186/1756-0500-2-76
3. Sheu CC, Lin SY, Chang YT, Lee CY, Chen YH, Hsueh PR. Management of infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: current evidence and future prospects. Expert Rev Anti Infect Ther. 2018;16(3):205–218. doi:10.1080/14787210.2018. 1436966
4. Elgendy SG, Abdel Hameed MR, El-Mokhtar MA. Tigecycline resistance among Klebsiella pneumoniae isolated from febrile neutropenic patients. J Med Microbiol. 2018;67(7):972–975. doi:10.1099/jmm.0.000770
5. Wu M, Li X. Chapter 87-Klebsiella pneumoniae and Pseudomonas aeruginosa. In: Tang Y-W, Sussman M, Liu D, Poxton I, Schwartzman J, editors. Molecular Medical Microbiology. 2nd ed. Boston: Academic Press; 2015:1547–1564.
6. Ramos-Vivas J, Chapartegui-Gonzalez I, Fernandez-Martinez M, et al. Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients. Sci Rep. 2019;9(1):8928. doi:10.1038/s41598-019-45060-y
7. Rasamiravaka T, Labtani Q, Duez P, El Jaziri M. The formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms. Biomed Res Int. 2015;2015:759348. doi:10.1155/2015/759348
8. Rushdy AA, Gomaa EZ. Antimicrobial compounds produced by probiotic Lactobacillus brevis isolated from dairy products. Ann Microbiol. 2013;63(1):81–90. doi:10.1007/s13213-012-0447-2
9. Inglin RC, Stevens MJ, Meile L, Lacroix C, Meile L. High-throughput screening assays for antibacterial and antifungal activities of Lactobacillus species. J Microbiol Methods. 2015;114:26–29. doi:10.1016/j.mimet.2015.04.011
10. Chen CC, Lai CC, Huang HL, et al. Antimicrobial activity of lactobacillus species against carbapenem-resistant enterobacteriaceae. Front Microbiol. 2019;10:789. doi:10.3389/fmicb.2019.00789
11. Kumar M, Dhaka P, Vijay D, et al. Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli. Int J Antimicrob Agents. 2016;48 (3):265–270. doi:10.1016/j.ijantimicag.2016.05.014
12. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol. 1998;93(11):2097–2101. doi:10.1111/j.1572-0241.1998.00600.x
13. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol. 1997;63(2):513–518. doi:10.1128/AEM.63.2.513-518.1997
14. Zhang Y, Shi X, Hao S, et al. Inhibition of Shigella sonnei-induced epithelial barrier disruption by surface-layer associated proteins of lactobacilli from Chinese fermented food. J Dairy Sci. 2018;101 (3):1834–1842. doi:10.3168/jds.2017-13417
15. Shokri D, Khorasgani MR, Mohkam M, Fatemi SM, Ghasemi Y, Taheri-Kafrani A. The inhibition effect of lactobacilli against growth and biofilm formation of Pseudomonas aeruginosa. Probiotics Antimicrob Proteins. 2018;10(1):34–42. doi:10.1007/s12602-017-9267-9
16. Kang MS, Lim HS, Oh JS, et al. Antimicrobial activity of Lactobacillus salivarius and Lactobacillus fermentum against Staphylococcus aureus. Pathog Dis. 2017;75(2). doi:10.1093/femspd/ftx009
17. Bergey DH, Holt JG. Bergey’s Manual of Determinative Bacteriology. Williams & Wilkins; 1994.
18. Schillinger U. Isolation and identification of lactobacilli from novel-type probiotic and mild yoghurts and their stability during refrigerated storage. Int J Food Microbiol. 1999;47(1–2):79–87. doi:10.1016/S0168-1605(99)00014-8
19. Liu W, Bao Q, Qing M, et al. Isolation and identification of lactic acid bacteria from tarag in eastern inner Mongolia of China by 16S rRNA sequences and DGGE analysis. Microbiol Res. 2012;167 (2):110–115. doi:10.1016/j.micres.2011.05.001
20. CLSI. Performance standards for antimicrobial susceptibility testing: CLSI document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
21. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10(4):867–878. doi:10.1093/clinids/10.4.867
22. de Carvalho AA, de Paula RA, Mantovani HC, de Moraes CA. Inhibition of Listeria monocytogenes by a lactic acid bacterium isolated from Italian salami. Food Microbiol. 2006;23(3):213–219. doi:10.1016/j.fm.2005.05.009
23. Sancineto L, Piccioni M, De Marco S, et al. Diphenyl diselenide derivatives inhibit microbial biofilm formation involved in wound infection. BMC Microbiol. 2016;16(1):220. doi:10.1186/s12866-016-0837-x
24. Vijaya Kumar B, Vijayendra SV, Reddy OV. Trends in dairy and non-dairy probiotic products-a review. J Food Sci Technol. 2015;52 (10):6112–6124. doi:10.1007/s13197-015-1795-2
25. Weichselbaum E. Potential benefits of probiotics–main findings of an in-depth review. Br J Community Nurs. 2010;15(3):110,112,114. doi:10.12968/bjcn.2010.15.3.46897
26. Muhammad Z, Ramzan R, Abdelazez A, et al. Assessment of the antimicrobial potentiality and functionality of Lactobacillus plantarum strains isolated from the conventional inner Mongolian fermented cheese against foodborne pathogens. Pathogens. 2019;8 (2):71. doi:10.3390/pathogens8020071
27. Mirnejad R, Vahdati AR, Rashidiani J, Erfani M, Piranfar V. The antimicrobial effect of lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro. Iran Red Crescent Med J. 2013;15 (2):122–126. doi:10.5812/ircmj
28. Abedi D, Feizizadeh S, Akbari V, Jafarian-Dehkordi A. In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res Pharm Sci. 2013;8 (4):260–268.
29. Koohestani M, Moradi M, Tajik H, Badali A. Effects of cell-free supernatant of Lactobacillus acidophilus LA5 and Lactobacillus casei 431 against planktonic form and biofilm of Staphylococcus aureus. Vet Res Forum. 2018;9(4):301–306. doi:10.30466/vrf.2018.33086
30. Forestier C, De Champs C, Vatoux C, Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol. 2001;152(2):167–173. doi:10.1016/S0923-2508(01)01188-3
31. Strus M, Pakosz K, Gosciniak H, et al. Antagonistyczne dzialanie bakterii z rodzaju Lactobacillus wobec beztlenowych i mikroaer-ofilnych czynnikow zakazen przewodu pokarmowego (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile) [Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile)]. Med Dosw Mikrobiol. 2001;53(2): 133–142.
32. Bin Masalam MS, Bahieldin A, Alharbi MG, et al. Isolation, molecular characterization and probiotic potential of lactic acid bacteria in Saudi raw and fermented milk. Evid Based Complement Alternat Med. 2018;2018:7970463. doi:10.1155/2018/7970463
33. Yasui H, Kiyoshima J, Ushijima H. Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. J Infect Dis. 1995;172 (2):403–409. doi:10.1093/infdis/172.2.403
34. Angmo K, Kumari A, Savitri BTC. Probiotic characterization of lactic acid bacteria isolated from fermented foods and beverage of Ladakh. LWT Food Sci Technol. 2016;66:428–435. doi:10.1016/j. lwt.2015.10.057
35. Liong MT, Shah NP. Bile salt deconjugation ability, bile salt hydro-lase activity and cholesterol co-precipitation ability of lactobacilli strains. Int Dairy J. 2005;15(4):391–398. doi:10.1016/j.idairyj.2004. 08.007
36. Talib N, Mohamad NE, Yeap SK, et al. Isolation and characterization of Lactobacillus spp. from kefir samples in Malaysia. Molecules. 2019;24(14):2606. doi:10.3390/molecules24142606
37. Reuben RC, Roy PC, Sarkar SL, Alam R-U, Jahid IK. Isolation, characterization, and assessment of lactic acid bacteria toward their selection as poultry probiotics. BMC Microbiol. 2019;19(1):253. doi:10.1186/s12866-019-1626-0
38. Jamalifar H, Rahimi H, Samadi N, et al. Antimicrobial activity of different Lactobacillus species against multi-drug resistant clinical isolates of Pseudomonas aeruginosa. Iran J Microbiol. 2011;3 (1):21–25.
39. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol. 1988;34(3):339–343. doi:10.1139/m88-062
40. Reid G, Cook RL, Bruce AW. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol. 1987;138(2):330–335. doi:10.1016/S0022-5347(17)43137-5
41. Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun. 1985;47(1):84–89. doi:10.1128/IAI.47.1.84-89.1985
42. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001;32(1):37–41. doi:10.1111/j.1574-695X.2001.tb00531.x
43. Kim Y, Oh S, Kim SH. Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohe-morrhagic Escherichia coli O157: H7. Biochem Biophys Res Commun. 2009;379(2):324–329. doi:10.1016/j.bbrc.2008.12.053
44. Gan BS, Kim J, Reid G, Cadieux P, Howard JC. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J Infect Dis. 2002;185(9):1369–1372. doi:10.1086/jid.2002.185.issue-9
45. Alexandre Y, Le Berre R, Barbier G, Le Blay G. Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections. BMC Microbiol. 2014;14:107. doi:10.1186/1471-2180-14-107
46. Breidenstein EB, de la Fuente-núñez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19 (8):419–426. doi:10.1016/j.tim.2011.04.005
47. Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177–192. doi:10.1016/j.biotechadv.2018.11.013